Gilead Sciences Inc. (GILD) Financials Nov 20, 2014, 7:59
Gilead Sciences Inc. (GILD) Financials Nov 20, 2014, 7:59 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Gilead Sciences Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 6.93B 7.88B 8.46B 9.61B 11.22B
Cost of Goods Sold (COGS) incl. D&A 1.6B 1.87B 2.12B 2.47B 2.9B
COGS excluding D&A 1.38B 1.6B 1.82B 2.19B 2.55B
Depreciation & Amortization Expense 212.94M 265.48M 302.23M 278.21M 344.7M
Depreciation 64.56M 67.24M 72.19M 82.85M 102.64M
Amortization of Intangibles 148.38M 198.24M 230.05M 195.36M 242.06M
Gross Income 5.33B 6.01B 6.34B 7.14B 8.32B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.83B 2.09B 2.47B 3.22B 3.72B
Research & Development 914.22M 1.06B 1.23B 1.76B 2.12B
Other SG&A 912.09M 1.03B 1.24B 1.46B 1.6B
Other Operating Expense 0 0 0 0 0
Unusual Expense (9.41M) (115.36M) 56.56M 1.1M 74.85M
EBIT after Unusual Expense 9.41M 115.36M (56.56M) (1.1M) (74.85M)
Non Operating Income/Expense (29,000) (6.35M) 44.5M 52.63M (12M)
Non-Operating Interest Income 54.41M 0 0 0 0
Equity in Affiliates (Pretax) 0 - 0 - 0
Interest Expense 69.66M 108.96M 205.42M 360.92M 306.89M
Gross Interest Expense 69.66M 108.96M 205.42M 360.92M 306.89M
Interest Capitalized 0 0 0 0 -
Pretax Income 3.5B 3.91B 3.65B 3.61B 4.21B
Income Tax 876.36M 1.02B 861.95M 1.04B 1.15B
Income Tax - Current Domestic 873.15M 992.64M 767.04M 1.05B 1.22B
Income Tax - Current Foreign 42.86M 43.09M 39.92M 28.62M 45.54M
Income Tax - Deferred Domestic (38.46M) (12.39M) 50.94M (40.5M) (93.58M)
Income Tax - Deferred Foreign (1.19M) 454,000 4.04M (2.19M) (19.8M)
Income Tax Credits 0 - 0 - 0
Equity in Affiliates 0 - 0 - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 2.63B 2.89B 2.79B 2.57B 3.06B
Minority Interest Expense (10.16M) (11.51M) (14.58M) (17.97M) (17.52M)
Net Income 2.64B 2.9B 2.8B 2.59B 3.07B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 2.64B 2.9B 2.8B 2.59B 3.07B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 2.64B 2.9B 2.8B 2.59B 3.07B
EPS (Basic) 1.46 1.70 1.81 1.71 2.01
Basic Shares Outstanding 1.81B 1.71B 1.55B 1.51B 1.53B
EPS (Diluted) 1.41 1.66 1.78 1.64 1.81
Diluted Shares Outstanding 1.87B 1.75B 1.58B 1.58B 1.69B
EBITDA 3.72B 4.18B 4.17B 4.2B 4.95B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
When Pricing Sends the Wrong Message Jump into the high stakes poker game of Atlanta's luxury real estate, and you'll find that pricing strategy is your make-or-break move. Jud Whitlock, a seasoned veteran over at Atlanta Fine Homes/Sotheby's International Realty, lays it all down: in this digital age, pricing too high is akin to waving a red flag at savvy buyers armed...
Continue Reading
AI Transformation: Hard Reality or Strategic Opportunity? The future of work. That’s what everyone’s buzzing about lately, isn’t it? AI poised to shake every nook and cranny. You're either riding the wave or getting crushed by it. It’s no longer some distant prospect—the challenge is right here, now. Come September 23, Zellis Connect 2026 is plunging headfirst...
Continue Reading
EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...
Continue Reading
Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...
Continue Reading
Fosun International's Sustainability Milestone Now, you don't often see a company's sustainability rating climbing the ladder like a homesick angel, but Fosun International just nailed it. On September 7, 2026, their Hang Seng Sustainability Rating bumped up a notch from AA- to AA+, now at an all-time high. It's the sort of financial footnote that grabs the attention....
Continue Reading
Smarter Energy Systems Are Here Gone are the days when solar inverters were just clunky bits of tech you threw on a roof. Sungrow's latest MGTL Series, revealed in Da Nang, marks a revolutionary step for Southeast Asia, Africa, Latin America, and beyond. They're not just talking the talk—they're bringing real innovation to the table. Why the MGTL Series Stands Out Look,...
Continue Reading
Breaking New Ground with EXCiPACT Certification Here's a tale unfolding in the high-stakes world of biotechnology—CelluPro, a standout in cell culture media, just snagged the EXCiPACT™ certification. This isn't just some fancy plaque for the wall. It's a stamp of approval that screams reliability in the global biomanufacturing supply scene. Why This Certification...
Continue Reading
Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....
Continue Reading
A Technological Leap for French Rugby Innovation and precision in partnerships—those words don't usually pop up together when chatting about a rugby league. But here we are, discussing the TOP 14, the elite French rugby championship, pairing up with Segway Navimow. This brand, under the umbrella of Ninebot Limited (689009.SH), is stepping into the world of sports for...
Continue Reading
Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...
Continue Reading
Top 5 Most Recently Viewed Articles
Saudi Tourism Authority Impresses at WTM 2025 The Saudi Tourism Authority has showcased its commitment to becoming a premier global travel destination at World Travel Market (WTM) 2025. During this significant event, the Authority signed nine memorandums of understanding (MoUs) and facilitated an impressive twenty-seven agreements between Saudi partners and the...
Continue Reading
The Ademi Firm Explores Confluent's Proposed Sale The Ademi Firm, a renowned name in shareholder litigation, is currently investigating whether Confluent Inc. (NASDAQ: CFLT) is providing a fair value for its shareholders in the recent sale agreement with IBM. Key Details of the Transaction According to the agreement, each Confluent shareholder is set to receive $31 per...
Continue Reading
Integration of Scanifly and EcoFasten Enhances Efficiency Leading the charge in solar technology, Scanifly has partnered with EcoFasten to create a powerful integration that significantly optimizes the racking design process for solar installations. This collaboration is a game-changer, enabling contractors to save between one to three hours on each project. Key Features...
Continue Reading
Introduction of David Van Bibber at Shoals Technologies Group Recently, Shoals Technologies Group, Inc. announced a significant addition to their executive team with the appointment of David Van Bibber as Chief Accounting Officer. This strategic move highlights Shoals' commitment to strengthening its financial leadership in the energy transition market. David Van Bibber's...
Continue Reading
Overview of Financial Performance Q.E.P. Co., Inc. (OTCQX: QEPC), a prominent name in the flooring installation solutions industry, has recently released its financial results for the first six months and second quarter of fiscal 2026. Although the company faced various economic challenges, its resilience shines through in its latest performance metrics. Sales Performance...
Continue Reading